Publications by Dr Olivier Govaere - ePrints

Browsing publications by Dr Olivier Govaere.

Newcastle Authors	Title	Year
Professor Ann Daly Dr Olivier Govaere Dr Simon Cockell Professor Quentin Anstee	Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis	2024
Dr Olivier Govaere Dr Megan Hasoon Dr Simon Cockell Dr Dina Tiniakos Professor Ann Daly et al.	A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures	2023
Dr Olivier Govaere Professor Ann Daly	Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate	2023
Dr Olivier Govaere Professor Quentin Anstee	Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease	2023
Dr Kate Hallsworth Jadine Scragg Dr Leah Avery Laura Haigh Dr Olivier Govaere et al.	Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease	2023
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al.	Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?	2022
Dr Katherine Johnson Dr Peter Leary Dr Olivier Govaere Dr Matthew Barter Sarah Charlton et al.	Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance	2022
Dr Olivier Govaere Dr Rebecca Darlay Dr Julien Peltier Dr Jeremy Palmer Dr Massimo Younes et al.	Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease	2022
Dr Olivier Govaere Professor Ann Daly Professor Quentin Anstee	Metabolic signatures across the full spectrum of nonalcoholic fatty liver disease	2022
Dr Sam Tingle Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Olivier Govaere et al.	Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers	2022
Dr Olivier Govaere Professor Ann Daly Professor Quentin Anstee	Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease	2022
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al.	Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?	2022
Dr Massimo Younes Rachel Burgoyne Dr Dina Tiniakos Dr Olivier Govaere	Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease	2021
Marco Zaki Dr Ahmed Mahdi Dr Gillian Patman Anna Whitehead Joao Mauricio et al.	Key features of the environment promoting liver cancer in the absence of cirrhosis	2021
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Youssef William Zaki et al.	Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease	2021
Dr Olivier Govaere Dr Dina Tiniakos Professor Pierre Bedossa Dr Simon Cockell Dr Massimo Younes et al.	NASH limits anti-tumor surveillance in immunotherapy-treated HCC	2021
Professor Ann Daly Dr Olivier Govaere Professor Quentin Anstee	Peptide-Based Urinary Monitoring of Fibrotic Non-Alcoholic Steatohepatitis by Mass Barcoded Activity-Based Sensors	2021
Dr Olivier Govaere Dr Simon Cockell Professor Ann Daly Professor Quentin Anstee	Transcriptomics Identify Thrombospondin-2 as a Biomarker for Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis	2021
Dr Olivier Govaere Dr Dina Tiniakos Professor Quentin Anstee Professor Fiona Oakley	Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis	2020
Dr Olivier Govaere Professor Quentin Anstee	Erratum: Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC	2020
Professor Quentin Anstee Dr Rebecca Darlay Dr Simon Cockell Dr Olivier Govaere Dr Dina Tiniakos et al.	Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort	2020
Dr Olivier Govaere Professor Quentin Anstee	Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers	2020
Dr Olivier Govaere	Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD)	2020
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al.	Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease	2020
Dr Massimo Younes Dr Olivier Govaere Dr Luca Miele Dr Dina Tiniakos Professor Alastair Burt et al.	Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease	2020
Dr Olivier Govaere Dr Simon Cockell Dr Dina Tiniakos Dr Rachel Queen Dr Massimo Younes et al.	Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis	2020
Dr Hannah Paish Lee Reed Helen Brown Mark Bryan Dr Olivier Govaere et al.	A bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices	2019
Professor Quentin Anstee Professor Helen Reeves Dr Olivier Govaere	From NASH to HCC: current concepts and future challenges	2019
Dr Olivier Govaere Dr Simon Cockell Dr Arianna Bianchi	High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease	2019
Dr Marie Boyle Dr Dina Tiniakos Dr Olivier Govaere Dr Massimo Younes Professor Stuart McPherson et al.	Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease	2019
Dr Olivier Govaere	Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model	2019
Dr Olivier Govaere Misti McCain	The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers	2019
Dr Olivier Govaere	YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role	2019
Dr Olivier Govaere Dr Dina Tiniakos	Hepatic Progenitor Cells in Metastatic Liver Carcinomas	2018
Dr Olivier Govaere Professor Quentin Anstee	Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis	2018
Dr Olivier Govaere	Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma	2017
Dr Olivier Govaere	Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching	2017
Dr Olivier Govaere	Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy	2017
Dr Olivier Govaere	RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers	2017
Dr Olivier Govaere	The footprint of the ageing stroma in older patients with breast cancer	2017
Dr Olivier Govaere Professor Quentin Anstee	The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma	2017
Dr Olivier Govaere	Chemokine (C-C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury	2016
Dr Olivier Govaere Dr Sabine Klein	FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis	2016
Dr Olivier Govaere	Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples	2016
Dr Olivier Govaere	Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease	2016
Dr Olivier Govaere	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche	2016
Dr Olivier Govaere	Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma	2016
Dr Olivier Govaere	The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry	2016
Dr Olivier Govaere	Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems	2016
Dr Olivier Govaere	Expression of FOXP1 and Colorectal Cancer Prognosis	2015
Dr Olivier Govaere	Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis	2015
Dr Olivier Govaere	Pathogenesis and Prognosis of Hepatocellular Carcinoma at the Cellular and Molecular Levels	2015
Dr Olivier Govaere	Pituitary tumors contain a side population with tumor stem cell-associated characteristics	2015
Dr Olivier Govaere	Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure	2015
Dr Olivier Govaere	A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: Identification, characterization, and prognostic value	2014
Dr Olivier Govaere	Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis	2014
Dr Olivier Govaere	Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals	2014
Dr Olivier Govaere	Keratin 19: a key role player in the invasion of human hepatocellular carcinomas	2014